AN ACT CONCERNING MINORS EXPERIENCING GENDER DYSPHORIA OR INCONGRUENCE.

HB 6609 prohibits healthcare providers from prescribing puberty blockers, cross-sex hormones, or surgical interventions for minors under 18 to treat gender dysphoria or incongruence, except when FDA-approved for other medical uses. The bill directly affects minors under 18 experiencing gender dysphoria and their medical providers. It mandates that such minors receive psychotherapy instead of the prohibited medical treatments, aiming to align care with FDA-approved standards. The law focuses on restricting specific gender-affirming medical interventions for minors while promoting mental health support.